Total Funding
$104.8M
Employee Range
11-50
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells, and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
Celladon data powered by:
Share
Celladon data powered by:
CelladonOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
CelladonIndustry Rankings in
Healthtech
City Rank
Share
7th
In La Jolla
Top 42%out of 17 startups
National Rank
Share
2,421st
In United States
Top 28%out of 8869 startups
Regional Rank
Share
2,543rd
In North America
Top 27%out of 9671 startups
CelladonSubindustry Rankings in
BiotechnologyCity Rank
Share
7th
In La Jolla
Top 50%out of 14 startups
National Rank
Share
1,034th
In United States
Top 30%out of 3470 startups
Regional Rank
Share
1,072nd
In North America
Top 29%out of 3721 startups
rankings by:
CelladonSB Rank Evolution
Not enough data points to display the chart.
CelladonstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro